277 related articles for article (PubMed ID: 30268859)
1. In patients with unprovoked VTE, does the addition of FDG PET/CT to a limited occult cancer screening strategy offer good value for money? A cost-effectiveness analysis from the publicly funded health care systems.
Robin P; Kumar S; Salaun PY; Le Roux PY; Couturaud F; Planquette B; Merah A; Roy PM; Thavorn K; Le Gal G
Thromb Res; 2018 Nov; 171():97-102. PubMed ID: 30268859
[TBL] [Abstract][Full Text] [Related]
2. Limited screening with versus without (18)F-fluorodeoxyglucose PET/CT for occult malignancy in unprovoked venous thromboembolism: an open-label randomised controlled trial.
Robin P; Le Roux PY; Planquette B; Accassat S; Roy PM; Couturaud F; Ghazzar N; Prevot-Bitot N; Couturier O; Delluc A; Sanchez O; Tardy B; Le Gal G; Salaun PY;
Lancet Oncol; 2016 Feb; 17(2):193-199. PubMed ID: 26672686
[TBL] [Abstract][Full Text] [Related]
3. Additional testing following screening strategies for occult malignancy diagnosis in patients with unprovoked venous thromboembolism.
Robin P; Le Roux PY; Le Moigne E; Planquette B; Prévot-Bitot N; Roy PM; Pastre J; Merah A; Couturaud F; Le Gal G; Salaun PY
Thromb Res; 2017 Jul; 155():6-9. PubMed ID: 28460260
[No Abstract] [Full Text] [Related]
4. Performance of
Robin P; van Es N; Le Roux PY; Rondina M; Lecumberri R; Beckers M; Le Gal G; Salaun PY
Thromb Res; 2020 Oct; 194():153-157. PubMed ID: 32788108
[TBL] [Abstract][Full Text] [Related]
5. A pilot study utilizing whole body 18 F-FDG-PET/CT as a comprehensive screening strategy for occult malignancy in patients with unprovoked venous thromboembolism.
Rondina MT; Wanner N; Pendleton RC; Kraiss LW; Vinik R; Zimmerman GA; Heilbrun M; Hoffman JM; Morton KA
Thromb Res; 2012 Jan; 129(1):22-7. PubMed ID: 21802118
[TBL] [Abstract][Full Text] [Related]
6. Screening for occult malignancy with FDG-PET/CT in patients with unprovoked venous thromboembolism.
Alfonso A; Redondo M; Rubio T; Del Olmo B; Rodríguez-Wilhelmi P; García-Velloso MJ; Richter JA; Páramo JA; Lecumberri R
Int J Cancer; 2013 Nov; 133(9):2157-64. PubMed ID: 23616232
[TBL] [Abstract][Full Text] [Related]
7. Performance of 18F-fluorodesoxyglucose positron-emission tomography combined with low-dose computed tomography for cancer screening in patients with unprovoked venous thromboembolism.
Robin P; Le Roux PY; Lacut K; Planquette B; Prévot-Bitot N; Lavigne C; Pastre J; Merah A; Le Gal G; Salaun PY
PLoS One; 2017; 12(6):e0178849. PubMed ID: 28570648
[TBL] [Abstract][Full Text] [Related]
8. Cost effectiveness of the addition of a comprehensive CT scan to the abdomen and pelvis for the detection of cancer after unprovoked venous thromboembolism.
Coyle K; Carrier M; Lazo-Langner A; Shivakumar S; Zarychanski R; Tagalakis V; Solymoss S; Routhier N; Douketis J; Coyle D
Thromb Res; 2017 Mar; 151():67-71. PubMed ID: 28160670
[TBL] [Abstract][Full Text] [Related]
9. Screening for Occult Cancer in Unprovoked Venous Thromboembolism.
Carrier M; Lazo-Langner A; Shivakumar S; Tagalakis V; Zarychanski R; Solymoss S; Routhier N; Douketis J; Danovitch K; Lee AY; Le Gal G; Wells PS; Corsi DJ; Ramsay T; Coyle D; Chagnon I; Kassam Z; Tao H; Rodger MA;
N Engl J Med; 2015 Aug; 373(8):697-704. PubMed ID: 26095467
[TBL] [Abstract][Full Text] [Related]
10. Effect of occult cancer screening on mortality in patients with unprovoked venous thromboembolism.
Robin P; Otten HM; Delluc A; van Es N; Carrier M; Salaün PY; Le Gal G
Thromb Res; 2018 Nov; 171():92-96. PubMed ID: 30268858
[TBL] [Abstract][Full Text] [Related]
11.
Delluc A; Robin P
Thromb Res; 2022 May; 213 Suppl 1():S42-S45. PubMed ID: 36210560
[No Abstract] [Full Text] [Related]
12. Positron emission tomography combined with computed tomography as a screening tool for occult malignancy in patients with unprovoked venous thromboembolism: an observational study.
Chauchard M; Benali K; Papo T; Sacre K
Medicine (Baltimore); 2014 Nov; 93(21):e110. PubMed ID: 25380083
[TBL] [Abstract][Full Text] [Related]
13. Cost-effectiveness analysis of 18F-FDG PET/CT in detecting suspected recurrence or metastasis in well-differentiated thyroid carcinoma patients with negative diagnostic total body scan in Thailand: a decision analysis.
Khiewvan B; Nopmaneejumruslers C; Pusuwan P; Tuchinda P; Tojinda N; Ubolnuch K
J Med Assoc Thai; 2013 Oct; 96(10):1350-64. PubMed ID: 24350419
[TBL] [Abstract][Full Text] [Related]
14. Venous thromboembolism and occult cancer: impact on clinical practice.
Gheshmy A; Carrier M
Thromb Res; 2016 Apr; 140 Suppl 1():S8-11. PubMed ID: 27067984
[TBL] [Abstract][Full Text] [Related]
15. 18FDG-PET-CT in the follow-up of non-small cell lung cancer patients after radical radiotherapy with or without chemotherapy: an economic evaluation.
van Loon J; Grutters JP; Wanders R; Boersma L; Dingemans AM; Bootsma G; Geraedts W; Pitz C; Simons J; Brans B; Snoep G; Hochstenbag M; Lambin P; De Ruysscher D
Eur J Cancer; 2010 Jan; 46(1):110-9. PubMed ID: 19944595
[TBL] [Abstract][Full Text] [Related]
16. Occult cancer and thromboembolism: current epidemiology and its practical implications.
Chao CH; Wang HY; Kao CH
Pol Arch Intern Med; 2018 Sep; 128(9):539-544. PubMed ID: 30057385
[TBL] [Abstract][Full Text] [Related]
17. Evaluating the use of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in the workup of Staphylococcus aureus bacteraemia: a cost-utility analysis.
Ong SWX; Zhabokritsky A; Daneman N; Tong SYC; Wijeysundera HC
Clin Microbiol Infect; 2023 Nov; 29(11):1417-1423. PubMed ID: 37353076
[TBL] [Abstract][Full Text] [Related]
18. Risk factors predictive of occult cancer detection in patients with unprovoked venous thromboembolism.
Ihaddadene R; Corsi DJ; Lazo-Langner A; Shivakumar S; Zarychanski R; Tagalakis V; Solymoss S; Routhier N; Douketis J; Le Gal G; Carrier M
Blood; 2016 Apr; 127(16):2035-7. PubMed ID: 26817957
[TBL] [Abstract][Full Text] [Related]
19. Clinical value of
Caspersen KB; Giannoutsou N; Gerke O; Alavi A; Høilund-Carlsen PF; Hess S
Ann Nucl Med; 2019 Mar; 33(3):184-192. PubMed ID: 30569441
[TBL] [Abstract][Full Text] [Related]
20. Risk factors of occult malignancy in patients with unprovoked venous thromboembolism.
Robin P; Le Roux PY; Tromeur C; Planquette B; Prévot-Bitot N; Lavigne C; Pastre J; Merah A; Couturaud F; Le Gal G; Salaun PY
Thromb Res; 2017 Nov; 159():48-51. PubMed ID: 28978463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]